摘要
目的:观察新血宝胶囊治疗慢性失血性贫血的疗效。方法:使用随机平行对照方法,将102例门诊慢性失血性贫血患者按照抛硬币方式随机分为2组,每组各51例。观察组患者口服新血宝胶囊,对照组患者口服硫酸亚铁,疗程均为4周。观察2组患者的临床疗效及不良反应发生情况。结果:观察组患者总有效率为94.11(48/51),明显高于对照组的78.43%(40/51),差异有统计学意义(P<0.05);观察组患者不良反应发生率为7.84%(4/51),明显低于对照组的35.19%(19/51),差异有统计学意义(P<0.05)。结论:新血宝胶囊治疗慢性失血性贫血疗效确切,无明显不良反应。
OBJECTIVE：To observe the efficacy of Xinxuebao capsule in treatment of chronic hemorrhagic anemia. METHODS： Random parallel control method was adopted, according to coin tossing, 102 cases with chronic hemorrhagic anemia were randomly divided into two groups, 51 cases in each group. The observation group was given oral Xinxuebao capsule treatment, and the control group treated with oral ferrous sulphate, the treatment course was 4 weeks. RESULTS： As for the treatment group, the total effective rate was 94. 11%（ 48/51 ） , significantly higher than the control group 78. 43%（40/51）, with statistically significant difference（P〈0. 05）. The incidence of ADR in the observation group was 7. 84%（ 4/51 ） , significantly lower than that in the control group 35. 19%（ 19/51 ） , with statistically significant difference （ P 〈0. 05 ） . CONCLUSIONS： The efficacy of Xinxuebao capsule in treatment of hemorrhagic anemia is effective, and there is no obvious ADR.
出处
《中国医院用药评价与分析》
2015年第8期1012-1014,共3页
Evaluation and Analysis of Drug-use in Hospitals of China
